GULLKNAPP PHARMA AS

4760 BIRKELAND

Finances

Share Ownership

Return on Equity

−40,96 %

Current Ratio

2,71

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	3 797 000	4 382 000	4 378 000	5 936 000
Net Income	−1 042 000	−256 000	224 000	1 280 000
Total Assets	4 019 000	4 927 000	4 354 000	5 896 000
Total Equity	2 544 000	3 586 000	3 841 000	3 617 000

Income (NOK)	2022	2021	2020	2019
Revenue	3 797 000	4 382 000	4 378 000	5 936 000
Expenditure	4 767 000	4 715 000	3 980 000	4 272 000
Operating Profit	−970 000	−331 000	398 000	1 664 000
Financial Income	6 000	6 000	4 000	19 000
Financial Costs	6 000	2 000	110 000	50 000
Financial Balance	0	4 000	−106 000	−31 000
Earnings Before Tax	−970 000	−327 000	292 000	1 634 000
Tax	71 000	−71 000	68 000	354 000
Net Income	−1 042 000	−256 000	224 000	1 280 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	23 000	107 000	49 000	61 000
Total Current Assets	3 996 000	4 819 000	4 305 000	5 835 000
Total Assets	4 019 000	4 927 000	4 354 000	5 896 000
Total Retained Equity	2 444 000	3 485 000	3 741 000	3 517 000
Total Equity	2 544 000	3 586 000	3 841 000	3 617 000
Total Long-Term Debt	0	0	0	70 000
Total Current Debt	1 475 000	1 341 000	512 000	2 209 000
Total Equity and Debt	4 019 000	4 927 000	4 354 000	5 896 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	3 792 000	4 358 000	4 370 000	4 168 000
Other Income	5 000	24 000	9 000	1 767 000
Revenue	3 797 000	4 382 000	4 378 000	5 936 000
Cost of Goods Sold	1 183 000	1 004 000	247 000	869 000
Salary Costs	1 612 000	1 594 000	1 439 000	1 187 000
Depreciation	13 000	13 000	13 000	2 000
Impairment	0	0	0	0
Expenditure	4 767 000	4 715 000	3 980 000	4 272 000
Operating Profit	−970 000	−331 000	398 000	1 664 000
Financial Income	6 000	6 000	4 000	19 000
Financial Costs	6 000	2 000	110 000	50 000
Financial Balance	0	4 000	−106 000	−31 000
Dividends	0	0	0	200 000
Net Income	−1 042 000	−256 000	224 000	1 280 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	71 000	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	23 000	36 000	49 000	61 000
Total Tangible Assets	23 000	36 000	49 000	61 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	23 000	107 000	49 000	61 000
Stock	3 234 000	3 661 000	3 493 000	3 016 000
Total Investments	0	0	0	0
Cash, Bank	134 000	552 000	166 000	1 884 000
Total Current Assets	3 996 000	4 819 000	4 305 000	5 835 000
Total Assets	4 019 000	4 927 000	4 354 000	5 896 000
Total Equity	2 544 000	3 586 000	3 841 000	3 617 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	70 000
Creditors	352 000	526 000	63 000	566 000
Unpaid Taxes	110 000	160 000	187 000	118 000
Dividends	0	0	0	200 000
Other Current Debt	1 013 000	655 000	195 000	971 000
Total Current Debt	1 475 000	1 341 000	512 000	2 209 000
Total Equity and Debt	4 019 000	4 927 000	4 354 000	5 896 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−40,96 %	−7,14 %	5,83 %	35,39 %
Debt-to-Equity Ratio	0	0	0	0,02
Operating Profit Margin	−25,55 %	−7,55 %	9,09 %	28,03 %
Current Ratio	2,71	3,59	8,41	2,64
Quick Ratio	−2,27	−2,08	−1,44	−7,23
Equity Ratio	0,63	0,73	0,88	0,61
Gross Profit Margin	68,84 %	77,09 %	94,36 %	85,36 %